All the patients in the phase 2 study received cyclophosphamide, tacrolimus and mycophenolate mofetil for graft-vs-host ...

Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing ...

Two allogeneic stem cell transplants, including a complex and highly challenging haploidentical (half-match) transplant were performed successfully at KIMS-Health Cancer Centre, marking a significant ...

Cayden Addison is battling a rare form of leukemia known as Philadelphia chromosome, which affects only 3% of patients. He ...

A local car dealership has sent warm wishes to Franciscan cancer patients.

And donating blood three times per year could possibly save you, according to researchers at the Francis Crick Institute in ...

The Global CAR-T Cell Therapy for Pediatric Cancers Market is expected to reach at a CAGR of 26.8% during the forecast period 2025-2033. The CAR-T Cell Therapy for Pediatric Cancers Market is ...

DelveInsight’s, “Chronic Lymphocytic Leukemia Pipeline Insight 2025” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Chronic Lymphocytic Leukemia (CLL) pipeline ...

Revolutionary advancements in blood cancer treatment, from targeted therapy to gene editing, promise more effective and ...

Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...

Bubbly and full of zeal, the Pomona resident remains positive despite facing his second battle with the disease. He expressed ...

Acute myeloid leukemia (AML) is an aggressive blood cancer characterized by the accumulation of immature myeloid cells. Current treatments often fail to achieve durable remission, underscoring the ...